- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Equipment
Snapshot for Affymetrix Inc (AFFX)
| Open: | 4.9500 | Day's Range: | 4.9100 - 5.0400 | Volume: | 392,614 | Bid: | 4.9500 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 4.9300 | 52wk Range: | 3.6800 - 8.1600 | 1-Yr Rtn: | -17.20% | Ask: | 4.9600 |
Key Statistics for AFFX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.4300 |
| Est. EPS (USD) (12/2012) | -0.2190 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 349.41 |
| Shares Outstanding (M) | 70.45 |
| Enterprise Value (M USD) (ttm) | 230.24 |
| Enterprise Value/EBITDA (ttm) | 28.98 |
| Price/Book (mrq) | 1.2809 |
| Price/Sale (ttm) | 1.3362 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More AFFX Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for AFFX
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for AFFX
Affymetrix, Inc. develops and manufactures DNA chip technology. The Company's GeneChip system acquires, analyzes, and manages genetic information in order to improve the diagnosis, monitoring, and treatment of disease. Affymetrix's product consists of DNA probe arrays containing gene sequences on a chip, a scanner to process the probe arrays, and software to analyze the information.
| Stephen P A FodorChairman/Founder | Franklin R Witney "Frank"President/CEO |
| Timothy C Barabe "Tim"Exec VP/CFO | Andrew J LastExec VP/Chief Commercial Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page